NCT06642116View on ClinicalTrials.gov

Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

July 31, 2025

Conditions
Rhinosinusitis ChronicWound HealingSinus SurgeryMometasone Furoate
Interventions
DEVICE

OCEAN

Biodegradable nasal dressing

Sponsors

Lead Sponsor

Polyganics BV

Collaborators (1)

NAMSA
All Listed Sponsors
collaborator

NAMSA

OTHER

lead

Polyganics BV

INDUSTRY

NCT06642116 - Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate | Biotech Hunter | Biotech Hunter